-
1
-
-
77953141740
-
Adalimumab-induced acute pneumonitis in a patient with rheumatoid arthritis
-
Dascalu C, Mrejen-Shakin K, Bandagi S. Adalimumab-induced acute pneumonitis in a patient with rheumatoid arthritis. J Clin Rheumatol 16: 172-174, 2010.
-
(2010)
J Clin Rheumatol
, vol.16
, pp. 172-174
-
-
Dascalu, C.1
Mrejen-Shakin, K.2
Bandagi, S.3
-
2
-
-
33749590024
-
Adalimumab-associated pulmonary fibrosis
-
Huggett MT, Armstrong R. Adalimumab-associated pulmonary fibrosis. Rheumatology (Oxford) 45: 1312-1313, 2006.
-
(2006)
Rheumatology (Oxford)
, vol.45
, pp. 1312-1313
-
-
Huggett, M.T.1
Armstrong, R.2
-
3
-
-
71349084643
-
Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment
-
Taki H, Kawagishi Y, Shinoda K, et al. Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment. Rheumatol Int 30: 275-276, 2009.
-
(2009)
Rheumatol Int
, vol.30
, pp. 275-276
-
-
Taki, H.1
Kawagishi, Y.2
Shinoda, K.3
-
4
-
-
84863532579
-
Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis
-
DOI:10.1007/s00296-009-1350-4 [Epub ahead of print]
-
Cho SK, Oh IH, Park CK, Bae SC, Sung YK. Etanercept induced organizing pneumonia in a patient with rheumatoid arthritis. Rheumatol Int DOI:10.1007/s00296-009-1350-4 [Epub ahead of print] 2010.
-
(2010)
Rheumatol Int
-
-
Cho, S.K.1
Oh, I.H.2
Park, C.K.3
Bae, S.C.4
Sung, Y.K.5
-
5
-
-
78049346486
-
A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis
-
Yamazaki H, Isogai S, Sakurai T, Nagasaka K. A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis. Mod Rheumatol 20: 518-521, 2010.
-
(2010)
Mod Rheumatol
, vol.20
, pp. 518-521
-
-
Yamazaki, H.1
Isogai, S.2
Sakurai, T.3
Nagasaka, K.4
-
6
-
-
0036382949
-
Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition
-
Vassallo R, Matteson E, Thomas CF Jr. Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor-alpha inhibition. Chest 122: 1093-1096, 2002.
-
(2002)
Chest
, vol.122
, pp. 1093-1096
-
-
Vassallo, R.1
Matteson, E.2
Thomas Jr., C.F.3
-
7
-
-
32544459602
-
Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab
-
Schoe A, van der Laan-Baalbergen NE, Huizinga TW, Breedveld FC, van Laar JM. Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab. Arthritis Rheum 55: 157-159, 2006.
-
(2006)
Arthritis Rheum
, vol.55
, pp. 157-159
-
-
Schoe, A.1
van der Laan-Baalbergen, N.E.2
Huizinga, T.W.3
Breedveld, F.C.4
van Laar, J.M.5
-
8
-
-
55549114365
-
Etanercept for idiopathic pulmonary fibrosis: Lessons on clinical trial design
-
Jackson RM, Fell CD. Etanercept for idiopathic pulmonary fibrosis: Lessons on clinical trial design. Am J Respir Crit Care Med 178: 889-891, 2008.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 889-891
-
-
Jackson, R.M.1
Fell, C.D.2
-
9
-
-
0034264117
-
Pulmonary drug toxicity: Radiologic and pathologic manifestations
-
Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC. Pulmonary drug toxicity: Radiologic and pathologic manifestations. Radiographics 20: 1245-1259, 2000.
-
(2000)
Radiographics
, vol.20
, pp. 1245-1259
-
-
Rossi, S.E.1
Erasmus, J.J.2
McAdams, H.P.3
Sporn, T.A.4
Goodman, P.C.5
-
10
-
-
21844444817
-
Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease
-
Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127: 2019-2027, 2005.
-
(2005)
Chest
, vol.127
, pp. 2019-2027
-
-
Lee, H.K.1
Kim, D.S.2
Yoo, B.3
-
11
-
-
55549147184
-
Treatment of idiopathic pulmonary fibrosis with etanercept: An exploratory, placebocontrolled trial
-
Raghu G, Brown KK, Costabel U, et al. Treatment of idiopathic pulmonary fibrosis with etanercept: An exploratory, placebocontrolled trial. Am J Respir Crit Care Med 178: 948-955, 2008.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 948-955
-
-
Raghu, G.1
Brown, K.K.2
Costabel, U.3
-
12
-
-
0028286946
-
Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice
-
Piguet PF, Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 7: 515-518, 1994.
-
(1994)
Eur Respir J
, vol.7
, pp. 515-518
-
-
Piguet, P.F.1
Vesin, C.2
-
13
-
-
0029008888
-
The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis
-
Golden MR, Katz RS, Balk RA, Golden HE. The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. J Rheumatol 22: 1043-1047, 1995.
-
(1995)
J Rheumatol
, vol.22
, pp. 1043-1047
-
-
Golden, M.R.1
Katz, R.S.2
Balk, R.A.3
Golden, H.E.4
-
14
-
-
34547455366
-
Rheumatoid arthritis treatment and the risk of severe interstitial lung disease
-
Wolfe F, Caplan L, Michaud K. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand J Rheumatol 36: 172-178, 2007.
-
(2007)
Scand J Rheumatol
, vol.36
, pp. 172-178
-
-
Wolfe, F.1
Caplan, L.2
Michaud, K.3
-
15
-
-
77953724167
-
Influence of anti-tnf therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: Results from the British Society for Rheumatology Biologics Register
-
British Society for Rheumatology Biologics R
-
Dixon WG, Hyrich KL, Watson KD, Lunt M, Consortium BCC, Symmons DP; British Society for Rheumatology Biologics R. Influence of anti-tnf therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: Results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 69: 1086-1091, 2010.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 1086-1091
-
-
Dixon, W.G.1
Hyrich, K.L.2
Watson, K.D.3
Lunt, M.4
Consortium, B.C.C.5
Symmons, D.P.6
|